Name | 7-benzyloxyindole crystalline |
Synonyms | NSC 92526 7-BENZYLOXYINDOLE 7-Benzyloxyindole 7-Benzyloxy-1H-indole 7-(PHENYLMETHOXY)INDOLE 7-(Phenylmethoxy)-1H-indole 1H-Indole,7-(phenylMethoxy)- 7-benzyloxyindolecrystalline 7-benzyloxyindole crystalline |
CAS | 20289-27-4 |
InChI | InChI=1/C15H13NO/c1-2-5-12(6-3-1)11-17-14-8-4-7-13-9-10-16-15(13)14/h1-10,16H,11H2 |
Molecular Formula | C15H13NO |
Molar Mass | 223.27 |
Density | 1.196±0.06 g/cm3(Predicted) |
Melting Point | 70-74 °C |
Boling Point | 411.6±20.0 °C(Predicted) |
Flash Point | 148.9°C |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Vapor Presure | 1.31E-06mmHg at 25°C |
Appearance | grayish crystalline powder |
Color | Light Red |
pKa | 16.36±0.30(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.669 |
MDL | MFCD00037974 |
Hazard Symbols | Xi - Irritant |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
HS Code | 29339990 |
Hazard Class | IRRITANT |
Overview | 7-benzyloxyindole is an organic intermediate, it can be prepared by reacting 7-hydroxyindole with benzyl bromide. |
preparation | 7-hydroxyindole (300 mg) was dissolved in dimethylformamide (2.0), to the solution were added potassium carbonate (622.6 mg) and benzyl bromide (295 μL) at room temperature, and the mixture was stirred at room temperature overnight. Distilled water and ethyl acetate were added to the reaction mixture for extraction, and the organic layer was washed twice with distilled water, then dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (Hexane: ethyl acetate = 10: 1) to obtain 7-benzyloxyindole (384mg). |
Use | for the preparation of pyrazolo quinoline derivatives as adenosine receptor antagonists; For the asymmetric total synthesis of azide Amides; for the preparation of HCV inhibitors; For the preparation of substituted 3-cyanoindoles and 3-(4-pyridyl) indoles as inhibitors of creatine monophosphate dehydrogenase in peripheral mononuclear blood cells (PMBC) has anti-proliferative activity; For the preparation of indolylmethylhydantoin and thiohydantoin derivatives for the treatment of apoptosis; For the preparation of ED-110, regioisomeric analogs |